Abstract
From September 1989 until September 1993, stool specimens and sera from 113 children with diarrhoea-associated haemolytic uraemic syndrome (HUS) from the Netherlands, two university hospitals in Belgium and one university hospital in Germany were examined for the presence of verocytotoxin-producingEscherichia coli (VTEC) infection. Evidence for VTEC infection was observed in 88 (78%) patients with HUS compared to 2 (3%) of the 65 children with acute gastro-enteritis Serotype O157 was the causative agent in 76 (86%) of these 88 patients with VTEC-associated HUS and verocytotoxin-2 (VT-2) was the most frequent toxin produced. Serological testing for antibodies to O157 O-antigen yielded the highest number of positive results compared to the other test methods. Antibodies to O157 were found in sera of 71 (65%) of 110 patients with HUS and one control serum. Stool and sera examination for VTEC in 95 family contacts of 28 patients with HUS demonstrated an evidence for VTEC infection 33 (35%). In contrast, in patients with HUS serological antibodies to O157 O-antigen were found in only 3 (4%) of 85 family contacts.
Similar content being viewed by others
Abbreviations
- HUS :
-
haemolytic uraemic syndrome
- VT :
-
verocytotoxin
- VTEC :
-
verocytotoxin-producingEscherichia coli
References
Bitzan M, Klemt KL, König H, Büren J, Müller-Wiefel DE (1993) The role ofEscherichia coli O157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Epidemiol Infect 110:183–196
Bokete TN, O'Callaghan CM, Clausen CR, Tang NM, Tran N, Mosely SL, Fritsche TR, Tarr PI (1993) Shiga-like toxin-producingEscherichia coli in Seattle children: a propspctive study. Gastroenterol 105:1724–1731
Boyce TG, Swerdlow DL, Griffin PM (1995)Escherichia coli O157: H7 and the hemolytic uremic syndrome. N Engl J Med 333:364–368
Caprioli A, Luzzi I, Rosmini F, Pasquini P, Cirrincone R, Gianviti A, Matteucer MC, Rizzoni G (1992) Hemolytic uremic syndrome and verocytotoxin-producingEscherichia coli intection in Italy. J Infect Dis 166:154–158
Chart H, Smith HR, Scotland SM, Rowe B, Milford DV, Taylor CM (1991) Serological identification ofEscherichia coli O157: H7 infection in haemolytic uraemic syndrome. Lancet 337:138–140
Fong JS, De Chadarevian JP, Kaplan BS (1982) Hemolytic uremic syndrome. Current concepts and management. Fediatr North Am 29:835–856
Heuvelink AE, NCAJ van de Kar, Meis JFGM, Monnens LAH, Melchers WJG (1995) Characterization of verocytotoxin-producingEscherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect 115:1–14
Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H (1985) The association between idiopathic hemolytic uremic syndrome and infection by Verotoxin-producingEscherichia coli. J Infect Dis 151:775–782
Remuzzi G, Ruggenenti P (1995) The hemolytic uremic syndrome. Kidney Int 47:2–19
Rowe PC, Orrbine E, Lior H, Wells GA, McLaine PN (1993) A prospective study of exposure to verotoxin-producingEscherichia coli among Canadian children with haemolytic uraemic syndrome. Epidemiol Infect 110:1–7
Tarr PI, Neill MA, Clausen CR, Watkins SI, Christie DL, Hickman RO (1990)Escherichia coli O157: H7 and the hemolytic uremic syndrome: importance of earlycultures in establishing the etiology. J Infect Dis 162:553–556
Thomas A, Chart H, Cheasty T, Smith HR, Frost JA, Rowe B (1993) Vero cytotoxin-producingEscherichia coli, particularly serogroup O157, associated with human infections in the United Kingdom: 1989–1991. Epidemiol Infect 110:591–600
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van de Kar, N.C.A.J., Roelofs, H.G.R., Muytjens, H.L. et al. Verocytotoxin-producingEscherichia coli infection in hemolytic uremic syndrome in part of Western Europe. Eur J Pediatr 155, 592–595 (1996). https://doi.org/10.1007/BF01957911
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957911